Evidence map›Paper›PMID 32849652›Full record

ReviewFrontiers in immunology2020

Immunoglobulin M: An Ancient Antiviral Weapon - Rediscovered.

Siqi Gong, Ruth M Ruprecht

Open access · goldAbstract readReview
In one paragraph

Review in Frontiers in immunology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 63 papers.

0numbers the graph read from it
0cells of the map it votes in
63citing papers in PubMed
3.1field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

63 citing papers in PubMed, 91 citations in OpenAlex.

  1. Adaptive Immunity in Marsupials.Journal of experimental zoology. Part A, Ecological and integrative physiology · 2026
    Review
  2. Article
  3. Enterovirus infections in children.Pediatric investigation · 2026
    Review
  4. Review
  5. Transcriptomic Analysis ofInternational journal of molecular sciences · 2026
    Article
  6. Transcriptomic Analysis ofbioRxiv : the preprint server for biology · 2026
    Article
  7. Article
  8. Review
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article

3 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 2 institutions in 1 country.

Siqi GongNew Iberia Research Center, University of Louisiana at Lafayette, New Iberia, LA, United States.
Ruth M RuprechtNew Iberia Research Center, University of Louisiana at Lafayette, New Iberia, LA, United States.
The University of Texas Health Science Center at San Antonio · USUniversity of Louisiana at Lafayette · US

Funding

Virology and ImmunologyP01AI048240 · NIAID · UNIVERSITY OF WASHINGTON · PI RUPRECHT, RUTH MARGRIT · 2000 to 2020
$46.7M
Humoral Correlates of Protection Against HIVR01AI100703 · NIAID · TEXAS BIOMEDICAL RESEARCH INSTITUTE · PI RUPRECHT, RUTH MARGRIT · 2012 to 2016
$4.0M
NIAID NIH HHS P01 AI048240NIAID NIH HHS R01 AI100703
6 · The paper itself

Abstract

Recent discoveries have shed new light onto immunoglobulin M (IgM), an ancient antibody class preserved throughout evolution in all vertebrates. First, IgM - long thought to be a perfect pentamer - was shown to be asymmetric, resembling a quasi-hexamer missing one monomer and containing a gap. Second, this gap allows IgM to serve as carrier of a specific host protein, apoptosis inhibitor of macrophages (AIM), which is released to promote removal of dead-cell debris, cancer cells, or pathogens. Third, recombinant IgM delivered mucosally by passive immunization gave proof-of-concept that this antibody class can prevent mucosal simian-human immunodeficiency virus transmission in non-human primates. Finally, IgM's role in adaptive immunity goes beyond being only a first defender to respond to pathogen invasion, as long-lived IgM plasma cells have been observed predominantly residing in the spleen. In fact, IgM produced by such cells contained somatic hypermutations and was linked to protection against lethal influenza virus challenge in murine models. Importantly, such long-lived IgM plasma cells had been induced by immunization 1 year before challenge. Together, new data on IgM function raise the possibility that vaccine strategies aimed at preventing virus acquisition could include this ancient weapon.

Indexed as

Adaptive ImmunityImmunity, MucosalAnimalsHost-Pathogen InteractionsHumansImmunizationImmunogenicity, VaccineImmunoglobulin MPlasma CellsSignal TransductionViral VaccinesVirus DiseasesVirusesImmunoglobulin MViral VaccinesIgM functionIgM structurepassive mucosal immunization with IgMprevention of mucosal virus transmission by IgMrecombinant monoclonal IgMvaccine-induced long-lived IgM plasma cells

Identifiers

PMID32849652
PMCPMC7432194
OpenAlexW3048380411

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.